TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
MXCT

MaxCyte Inc

Healthcare · Medical Devices

1.60$ -8.1% vs. previous close Closing price · As of: Oct 30, 2026

Ownership

Ownership Structure

Who owns MaxCyte Inc (MXCT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 90.8% of the shares are freely tradable; institutional investors hold 68.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 68.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.5%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 90.8%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 1.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 103Mio.

Largest Shareholders

Institutions

Institutions MXCT
Name Stake (%) Shares Change (%) Date
Capricorn Fund Managers Ltd 7.95 8,200,000 +0.0 06/30/2026
Vitruvian Partners 4.89 5,043,356 +0.0 06/30/2026
Vanguard Capital Management, LLC 3.91 4,031,284 +1.2 06/30/2026
Morgan Stanley - Brokerage Accounts 3.58 3,694,049 +0.2 06/30/2026
Mudita Advisors LLP 3.27 3,370,689 +0.0 06/30/2026
BlackRock Inc 2.97 3,060,960 -65.2 06/30/2026
Brooklands Fund Management Limited 2.76 2,848,083 +30.0 06/30/2026
BNP Paribas Investment Partners SA 2.69 2,773,554 +0.0 06/30/2026

Funds

Funds MXCT
Name Stake (%) Shares Change (%) Date
AXA Framlington Health Fund - R Income 2.69 2,773,554 +0.0 07/31/2026
Vanguard MStar Total Stk Mkt Idx Invest 2.66 2,742,125 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?